Trials in Anaheim, California
Here are the top 10 medical studies for prostate cancer in Anaheim, California
Popular Filters
Phase 3 Trials
AKT Inhibitor
Capivasertib + Docetaxel for Prostate Cancer
Recruiting1 awardPhase 3
Cerritos, California
This trial will compare the effect of two different treatments for metastatic prostate cancer. One group will receive a combination of capivasertib and docetaxel, while the other group will receive docetaxel and a placebo. The goal is to see if adding capivasertib to docetaxel improves survival rates.
Androgen Receptor Inhibitor
Darolutamide + ADT for Prostate Cancer
Recruiting1 awardPhase 3
Los Angeles, California
This trial is researching if a combination of ADT and darolutamide can help men with prostate cancer at high risk of biochemical recurrence (BCR) live longer without their cancer getting worse.
Trials With No Placebo
Monoclonal Antibodies
Vudalimab + Chemotherapy/Targeted Therapy for Prostate Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial will study the safety and effectiveness of XmAb20717 as a treatment for patients with metastatic prostate cancer who have been previously treated with other cancer therapies.
Androgen Receptor Inhibitor
ZEN003694 + Enzalutamide for Prostate Cancer
Recruiting1 awardPhase 2
Whittier, California
This trial is testing a new drug, ZEN003694, to see if it is more effective than the current standard of care, enzalutamide, in patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed on prior abiraterone. Patients will be randomized to receive either ZEN003694 in combination with enzalutamide or enzalutamide monotherapy. The primary endpoint is radiographic progression-free survival (rPFS) by PCWG3 criteria.
Monoclonal Antibodies
XB002 for Advanced Cancers
Recruiting2 awardsPhase 1
Los Angeles, California
This trial is testing a new drug, XB002, to see if it is safe and effective in treating advanced solid tumors. The trial will involve escalating doses of the drug to test for safety and tolerability, as well as expanding the study to additional patients.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.